Arun Wiita

Dr. Arun Wiita is a physician-scientist and Associate Professor in the Dept. of Laboratory Medicine and Dept. of Bioengineering & Therapeutic Sciences at the University of California, San Francisco. Dr. Wiita’s research laboratory focuses on mass spectrometry-based proteomics, target discovery, protein engineering, and cellular engineering toward the development of novel immunotherapies for hematologic malignancies, while his clinical duties center on molecular genomic pathology. Dr. Wiita also directs the UCSF Stephen and Nancy Grand Multiple Myeloma Translational Initiative (MMTI) Laboratory. Dr. Wiita is a prior recipient of the NIH Director’s New Innovator Award, a Clinical Scientist Development Award from the Doris Duke Charitable Foundation, and a Chan Zuckerberg Biohub Investigator Award, among others. He completed his residency in Clinical Pathology at UCSF, his MD and PhD at Columbia, with graduate training in single molecule biophysics, and undergraduate studies in Chemistry at Princeton.
Financial relationships
-
Attribution:SelfType of financial relationship:StockIneligible company:Indapta TherapeuticsDate added:12/13/2023Date updated:12/13/2023
-
Attribution:SelfType of financial relationship:OtherIneligible company:SanofiTopic:Speaker HonorariaDate added:12/13/2023Date updated:12/13/2023
-
Attribution:SelfType of financial relationship:OtherIneligible company:AstraZenecaTopic:Speaker HonorariaDate added:12/13/2023Date updated:12/13/2023